GL1X · GenesisL1 explorer

MolNFT v1 · #117259 · protein

Structure of human DPP3 in complex with angiotensin-II

5E2Q · Dipeptidyl peptidase 3: “Structure of human DPP3 in complex with angiotensin-II”. X-ray diffraction, 2 ligands (MG, K), 6 pockets (best druggability 0.81). MolNFT v1 #117259 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
5E2Q
Type
protein
Length
733 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dipeptidyl peptidase 3; Angiotensin-II
EC
3.4.14.4
UniProt
Q9NY33, P01019
Ligands
MG, K
Pockets
6 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 48% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADipeptidyl peptidase 3 (EC 3.4.14.4)protein72549% helix, 16% strandQ9NY33
BAngiotensin-IIprotein80% helix, 25% strandP01019

Ligands and binding sites

  • MG · Magnesium ion · metal · chains A
  • K · Potassium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11860.810.9549empty
23820.730.8458empty
33270.700.8349empty
42470.630.8240empty
5660.420.8019empty

Interfaces

1 interface between chains.

  • A–B · 1067 Ų buried · 22 hydrogen bonds · protein-protein

Compared structures

  • 5E2Q · Structure of human DPP3 in complex with angiotensin-II · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9NY33 · AlphaFold monomer V2.0 prediction for dipeptidyl peptidase 3 (Q9NY33) · a predicted model of the same protein · chain A against A, TM-score 1.00
  • P01019 · AlphaFold monomer V2.0 prediction for angiotensinogen (P01019) · a predicted model of the same protein · chain B against A, TM-score 0.55

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.